Search results
Mar 15, 2024 · In this World View, H. Michael Shepard describes his personal story behind the discovery of trastuzumab, 25 years since its FDA approval for HER2-overexpressing breast cancers.
H. Michael Shepard (born 1949) is an American cancer researcher who was awarded the 2007 Harvard Medical School Warren Alpert Foundation Prize and the 2019 Lasker Clinical research award, which he shared with Dennis Slamon and Axel Ullrich for their development of Herceptin
Dr. Michael Shepard is an orthopaedic surgeon who specializes in the treatment of knee, elbow and shoulder injuries in Orange and Irvine.
Nov 30, 2021 · Dr. Shepard, an innovator in the field of biotechnology and pioneer in cancer research, won the 2019 Lasker-DeBakey Clinical Medical Research Award with colleagues Dr. Dennis J. Slamon and Axel...
The 2019 Lasker~DeBakey Clinical Medical Research Award honors three scientists—H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich —who invented Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and developed it into a life-saving therapy for women with breast cancer. The innovation reduces the risk of ...
Michael F. Shepard, M.D. Dr Shepard is a board certified Orthopaedic Surgeon who is subspecialty trained in sports medicine with special emphasis on the care of the overhead athlete and knee ligament reconstruction.
Michael Shepard, M.D. is a board certified orthopedist at Hoag Orthopedict Institute, specializing in sports medicine treatment of the elbow, knee, and shoulder.
